KEYS vs RYTM · P/E 57, rev $4.98B vs rev $130.1M
Keysight Technologies Inc (KEYS) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the KEYS and RYTM stock pages for the full models.
Not investment advice.